These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 25672664)
1. Switching antipsychotic medication to aripiprazole: position paper by a panel of Italian psychiatrists. Fagiolini A; Brugnoli R; Di Sciascio G; De Filippis S; Maina G Expert Opin Pharmacother; 2015 Apr; 16(5):727-37. PubMed ID: 25672664 [TBL] [Abstract][Full Text] [Related]
2. Practical guidance for prescribing with aripiprazole in bipolar disorder. Fagiolini A Curr Med Res Opin; 2008 Sep; 24(9):2691-702. PubMed ID: 18702850 [TBL] [Abstract][Full Text] [Related]
3. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia. Wisniewski CS; Robert S Ann Pharmacother; 2012; 46(7-8):1097-104. PubMed ID: 22811346 [TBL] [Abstract][Full Text] [Related]
4. Practical prescribing with aripiprazole in schizophrenia: consensus recommendations of a UK multidisciplinary panel. Sullivan G; Bienroth M; Jones M; Millar H; Ratna L; Taylor D Curr Med Res Opin; 2007 Jul; 23(7):1733-44. PubMed ID: 17588303 [TBL] [Abstract][Full Text] [Related]
5. Aripiprazole in the treatment of schizophrenia: a consensus report produced by schizophrenia experts in Italy. Cassano GB; Fagiolini A; Lattanzi L; Monteleone P; Niolu C; Sacchetti E; Siracusano A; Vita A Clin Drug Investig; 2007; 27(1):1-13. PubMed ID: 17177576 [TBL] [Abstract][Full Text] [Related]
6. Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study. Casey DE; Carson WH; Saha AR; Liebeskind A; Ali MW; Jody D; Ingenito GG; Psychopharmacology (Berl); 2003 Apr; 166(4):391-9. PubMed ID: 12610718 [TBL] [Abstract][Full Text] [Related]
7. Aripiprazole in schizophrenia and schizoaffective disorder: A review. Stip E; Tourjman V Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550 [TBL] [Abstract][Full Text] [Related]
8. Aripiprazole for the treatment of bipolar disorder: a review of current evidence. Fagiolini A; Nitti M; Forgione RN; Marra FS; Casamassima F Expert Opin Pharmacother; 2011 Feb; 12(3):473-88. PubMed ID: 21254952 [TBL] [Abstract][Full Text] [Related]
9. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
10. Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance. Goodwin GM; Abbar M; Schlaepfer TE; Grunze H; Licht RW; Bellivier F; Fountoulakis KN; Altamura AC; Pitchot W; Ă…gren H; Holsboer-Trachsler E; Vieta E Curr Med Res Opin; 2011 Dec; 27(12):2285-99. PubMed ID: 22014287 [TBL] [Abstract][Full Text] [Related]
11. Aripiprazole in acute mania and long-term treatment of bipolar disorder: a critical review by an Italian working group. De Fazio P; Girardi P; Maina G; Mauri MC; Mauri M; Monteleone P; Perini GI; Perugi G; Rossi A Clin Drug Investig; 2010; 30(12):827-841. PubMed ID: 20923242 [TBL] [Abstract][Full Text] [Related]
12. Aripiprazole in treatment-refractory schizophrenia. Hsu WY; Lee CI; Chiu NY; Kahn DA J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396 [TBL] [Abstract][Full Text] [Related]
13. A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania. Dratcu L; Bobmanuel S; Davies W; Farmer A; George M; Rana T; Singh M; Turner M Int J Psychiatry Clin Pract; 2012 Oct; 16(4):244-58. PubMed ID: 22809129 [TBL] [Abstract][Full Text] [Related]
15. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services. Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125 [TBL] [Abstract][Full Text] [Related]
17. A UK consensus on the administration of aripiprazole for the treatment of mania. Aitchison KJ; Bienroth M; Cookson J; Gray R; Haddad PM; Moore B; Ratna L; Sullivan G; Taylor D; Taylor M; Goodwin GM J Psychopharmacol; 2009 May; 23(3):231-40. PubMed ID: 19010974 [TBL] [Abstract][Full Text] [Related]
18. Predictors of early worsening after switch to aripiprazole: a randomized, controlled, open-label study. Pae CU; Chiesa A; Mandelli L; Patkar AA; Gibiino S; Serretti A Clin Drug Investig; 2010; 30(3):187-93. PubMed ID: 20155991 [TBL] [Abstract][Full Text] [Related]
19. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Swainston Harrison T; Perry CM Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633 [TBL] [Abstract][Full Text] [Related]
20. A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder. Kim CY; Chung S; Lee JN; Kwon JS; Kim DH; Kim CE; Jeong B; Jeon YW; Lee MS; Jun TY; Jung HY Int Clin Psychopharmacol; 2009 Jul; 24(4):181-8. PubMed ID: 19451828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]